Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed and Refractory DLBCL

Clinical trial condition

Relapsed and Refractory DLBCL

Explore clinical trials studying Relapsed and Refractory DLBCL. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed and Refractory DLBCL trial results

Not Yet Recruiting

Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT07122609

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details